Alan Petro to the newly created position of vice president, Manufacturing and Technical Operations at MAP Pharmaceuticals. In his new role, Mr. Petro will lead the company’s efforts in the area of product/process development and manufacturing in order to prepare for the potential commercialization of the company’s lead product candidate, Levadex orally inhaled migraine therapy. Mr. Petro will report to Timothy S. Nelson, MAP’s president and chief executive officer. Mr. Petro...